Aptorum Group Announces Submission of Clinical Trial Application for ALS-4 an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)

NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Dec. 21, 2020 Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies for the treatment of a variety of medical conditions including infectious diseases, announced that the company, through its wholly owned subsidiary Aptorum International Limited, has […]

New Studies Conclude Xlear Kills and/or Deactivates SARS-CoV-2

MIAMI–(BUSINESS WIRE)–Nov. 30, 2020 New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective…and replicable means to deactivate SARS-CoV-2…to an undetectable amount of infectious virus.” This conclusion is “validated by two independent sets of experiments, performed by different labs, on different viral strains…” The Virucidal studies were […]

Humanigen Australia Proprietary Limited Established to Facilitate Asia-Pacific Growth Plans

New Humanigen entity in Australia creates focused opportunity for partnering, regional clinical trials and market access Structure allows for attractive financial incentives supported by the Australian government BURLINGAME, Calif.–(BUSINESS WIRE)–Nov. 24, 2020 Humanigen, Inc. (NASDAQ: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its […]

NTHU Researchers Discover New Gastric Cancer Biomarkers for Tailored Therapy

HSINCHU, Taiwan–(BUSINESS WIRE)–Nov. 14, 2020 A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua University (NTHU) has exploited the power of big data to identify two key biomarkers contributing to the proliferation and metastasis of gastric (stomach) cancer. Using the US Food and Drug Administration […]

Mevion Partners with Hermes Advanced Therapy Systems to Expand Reach in Asia

LITTLETON, Mass.–(BUSINESS WIRE)–Oct. 19, 2020 Mevion Medical Systems is pleased to announce it has entered a partnership agreement with Hermes Advanced Therapy Systems Corp. (HATS) for the distribution of the MEVION S250i Proton Therapy System® in Taiwan and Southeast Asia, including Malaysia, Thailand, and Singapore. As a subsidiary of Hermes-Epitek Corp., a trusted provider of […]

Private Group RLS (USA) Inc. Acquires GE Healthcare’s U.S. Radiopharmacy Network

TAMPA, Fla.–(BUSINESS WIRE)–Sep. 02, 2020 RLS (USA) Inc., (Radioisotope Life Sciences) has purchased General Electric’s (GE) U.S. radiopharmacy network, making it the largest pure molecular imaging focused firm in the United States. Capitor, (www.capitor.co) a boutique global financial advisory firm, structured and brought the deal to investors, playing a critical part in the years-long negotiation […]

Five of Kirin’s Proprietary Lactococcus lactis strain Plasma Products Registered as “Fo ods with Function Claims”

– First-ever Immune System Support Foods to Become Available in Japan – TOKYO–(BUSINESS WIRE)–Aug. 07, 2020 Kirin Holdings Company, Limited (TOKYO:2503) announced today that five of its products*1 that utilize Lactococcus lactis strain Plasma were registered as Foods with Function Claims with Japan’s Consumer Affairs Agency (CAA). This is the first time that an immune […]

LintonPharm Announces Authorization From China Health Authority to Proceed With a Global Phase 3 Trial Evaluating Catumaxomab in Advanced Gastric Cancer

GUANGZHOU, China–(BUSINESS WIRE)–Jul. 16, 2020 LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell engaging bispecific antibodies for cancer immunotherapy, today announced the China National Medical Products Administration (NMPA) authorized the company to proceed with a Phase III trial (clinicaltrials.gov: NCT04222114) for catumaxomab in patients with peritoneal carcinomatosis, a […]

Smiths Medical Acquires the Business of Access Scientific LLC Expanding Vascular Access Offering

MINNEAPOLIS–(BUSINESS WIRE)–May. 13, 2020 Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters. The range of POWERWAND™ […]

Supreme Court Rules in Favor of Hisky; Echosens (Shanghai) to Compensate Hisky for Its Illegal Acts Including Fabricating Information and Constituting Business Defaming

BEIJING–(BUSINESS WIRE)–May. 13, 2020 Recently, Shanghai Echosens Medical Equipment Technology Co., Ltd. (hereinafter referred to as “Echosens (Shanghai)”) and Fu-Rui Corporation, parent company of Echosens SAS, (hereinafter referred to as “Fu-Rui”), were determined by the Supreme People’s Court of China to have fabricated information to constitute business defaming against their opponent Wuxi HISKY Medical Technologies Co., Ltd. […]

Topcon Singapore Medical Announces its New Managing Director

Leo Hiroshi Nagatake leads the company from 1st April 2020. SINGAPORE–(BUSINESS WIRE)–Apr. 23, 2020 Topcon Singapore Medical Pte. Ltd. (“TSM”) has announced that Leo Hiroshi Nagatake, who is currently leading Topcon Healthcare Solutions Asia Pacific (”THSAP”), has been appointed as TSM’s new managing director. Leo has succeeded Calvin Lee, the former managing director of TSM, […]